Cilostazol increases patency and reduces adverse outcomes in percutaneous femoropopliteal revascularisation: a meta-analysis of randomised controlled trials

Alexandre M Benjo; Daniel C Garcia; J Stephen Jenkins; Rhanderson M N Cardoso; Taina P Molina; Georges E El-Hayek; Girish N Nadkarni; Emad F Aziz; James J Dinicolantonio; Tyrone Collins

doi:10.1136/openhrt-2014-000154

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Authors

About

Topic collection
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

PDF

Meta-analysis

Original research article

Cilostazol increases patency and reduces adverse outcomes in percutaneous femoropopliteal revascularisation: a meta-analysis of randomised controlled trials

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Benjo AM, Garcia DC, Jenkins JS, et al

Cilostazol increases patency and reduces adverse outcomes in percutaneous femoropopliteal revascularisation: a meta-analysis of randomised controlled trials

Open Heart 2014;1:e000154. doi: 10.1136/openhrt-2014-000154

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password